This inventor holds 3 USPTO granted patents. Top assignees: Repligen Corporation, Clariant Finance (Bvi) Limited. Active years: 1990-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990-1997
Title: Jennifer A. Jackson: A Trailblazer in Biotechnology
Introduction
Jennifer A. Jackson, based in Reading, Massachusetts, is a notable inventor whose work has significantly influenced the field of biotechnology. With a portfolio of three patents, her contributions focus on innovative methods for protein expression and lignin degradation, showcasing her expertise in genetic engineering and microbial systems.
Latest Patents
Jennifer's most recent inventions include:
1. **Cloning and Expression of Ligninases** - This patent involves the cloning and expression of the gene encoding the ligninase rLDM.TM. 6. The ligninases produced through this innovative process are particularly important for degrading or modifying lignin in pulp operations, providing an eco-friendly alternative for the industry.
2. **Novel Prokaryotic Expression and Secretion System** - In this patent, Jennifer develops a superior recombinant DNA expression/secretion system designed for prokaryotic organisms. This system enhances the production and secretion of useful proteins, which can otherwise be challenging to extract from engineered bacterial hosts.
Career Highlights
Throughout her career, Jennifer has demonstrated remarkable expertise, having worked for esteemed companies such as Repligen Corporation and Clariant Finance (BVI) Limited. Her role in these firms has contributed to advancing biotechnological applications and process efficiencies, making her a key player in the industry.
Collaborations
Jennifer's work has been enriched by collaborations with prominent scientists, including Salvador E. Luria and Joan L. Suit. Their combined knowledge and research efforts have amplified the potential impact of her innovations on biotechnology and related fields.
Conclusion
In summary, Jennifer A. Jackson stands out as a pioneering inventor in the biotechnology sector. Her patents not only address critical challenges in the industry but also pave the way for future advancements in protein production and environmental sustainability. Her journey exemplifies the profound impact that dedicated inventors can have on scientific progress and industrial practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile